147 related articles for article (PubMed ID: 35210605)
1. Omicron's lasting mysteries: four questions scientists are racing to answer.
Dance A
Nature; 2022 Mar; 603(7899):22-24. PubMed ID: 35210605
[No Abstract] [Full Text] [Related]
2. Omicron's feeble attack on the lungs could make it less dangerous.
Kozlov M
Nature; 2022 Jan; 601(7892):177. PubMed ID: 34987210
[No Abstract] [Full Text] [Related]
3. Where did Omicron come from? Three key theories.
Mallapaty S
Nature; 2022 Feb; 602(7895):26-28. PubMed ID: 35091701
[No Abstract] [Full Text] [Related]
4. Omicron's molecular structure could help explain its global takeover.
Kwon D
Nature; 2022 Feb; 602(7897):373-374. PubMed ID: 35115694
[No Abstract] [Full Text] [Related]
5. The emerging plasticity of SARS-CoV-2.
McCormick KD; Jacobs JL; Mellors JW
Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
[No Abstract] [Full Text] [Related]
6. Fast-spreading COVID variant can elude immune responses.
Callaway E
Nature; 2021 Jan; 589(7843):500-501. PubMed ID: 33479534
[No Abstract] [Full Text] [Related]
7. The coronavirus is here to stay - here's what that means.
Phillips N
Nature; 2021 Feb; 590(7846):382-384. PubMed ID: 33594289
[No Abstract] [Full Text] [Related]
8. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine breakthrough infections.
Gupta RK; Topol EJ
Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
[TBL] [Abstract][Full Text] [Related]
10. Why does the Omicron sub-variant spread faster than the original?
Callaway E
Nature; 2022 Feb; 602(7898):556-557. PubMed ID: 35177843
[No Abstract] [Full Text] [Related]
11. Heavily mutated Omicron variant puts scientists on alert.
Callaway E
Nature; 2021 Dec; 600(7887):21. PubMed ID: 34824381
[No Abstract] [Full Text] [Related]
12. Coronavirus variants are spreading in India - what scientists know so far.
Vaidyanathan G
Nature; 2021 May; 593(7859):321-322. PubMed ID: 33976409
[No Abstract] [Full Text] [Related]
13. Evolving threat.
Kupferschmidt K
Science; 2021 Aug; 373(6557):844-849. PubMed ID: 34413220
[No Abstract] [Full Text] [Related]
14. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
[No Abstract] [Full Text] [Related]
15. Closest known relatives of virus behind COVID-19 found in Laos.
Mallapaty S
Nature; 2021 Sep; 597(7878):603. PubMed ID: 34561634
[No Abstract] [Full Text] [Related]
16. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
Kannan S; Shaik Syed Ali P; Sheeza A
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
[TBL] [Abstract][Full Text] [Related]
17. Early lab studies shed light on Omicron's behavior.
Vogel G; Kupferschmidt K
Science; 2021 Dec; 374(6575):1543-1544. PubMed ID: 34941398
[No Abstract] [Full Text] [Related]
18. Omicron: a drug developer's perspective.
Fang FF; Shi PY
Emerg Microbes Infect; 2022 Dec; 11(1):208-211. PubMed ID: 34951568
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era.
Volkan E
Mol Biotechnol; 2021 Oct; 63(10):885-897. PubMed ID: 34145550
[TBL] [Abstract][Full Text] [Related]
20. The challenge of emerging SARS-CoV-2 mutants to vaccine development.
Li R; Liu J; Zhang H
J Genet Genomics; 2021 Feb; 48(2):102-106. PubMed ID: 33994322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
